We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Focus on HIV in Next Patient-Focused Drug Development Meeting
FDA to Focus on HIV in Next Patient-Focused Drug Development Meeting
May 20, 2013
HIV is the topic of the FDA’s second meeting intended to further its patient-centered research push; in a Federal Register notice today, the agency lists a series of questions it plans to ask HIV patients and advocates, including whether they have qualms about participating in cure research.